<DOC>
	<DOC>NCT00707538</DOC>
	<brief_summary>The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158</brief_summary>
	<brief_title>A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress</brief_title>
	<detailed_description />
	<criteria>age 1840 BMI 1830 kg/m2 No active or chronic illnesses If female: not pregnant, use of birth control or not of childbearing potential Significant active or chronic illness Any neurological disorder GI disease within 3 months Recent infection Major surgery within 4 weeks Donation of blood within 4 weeks Blood transfusion within 4 weeks Recent history drug/alcohol abuse Head trauma Significant screening ECG, EEG, lab tests, physical exam and vital signs abnormalities Prescription or OTC drugs within 2 weeks Exposure to any other investigational</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>